Connect with us

International

Cancer drug cooperation could save 1.5 mn lives a year: researchers

Ilustrative image

AFP

Around 1.5 million lives could be saved every year if the world worked together to more swiftly approve new cancer drugs, researchers said Tuesday.

The figure was based on how long it took two recent cancer drugs to be approved across the world after they were given the green light by the United States.

Pembrolizumab, an effective treatment for most lung cancers, was approved by the US Food and Drug Administration (FDA) in 2016.

More than 600,000 years of patients’ lives could have been saved if Brazil, Canada, China, India, Japan and the European Union had approved the drug at the same time, according to an analysis published in the Harvard Business Review, which is not peer-reviewed.

Advertisement
20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
previous arrow
next arrow

The authors, including US oncologist Bobby Daly, also looked at enzalutamide, which is used to treat prostate cancer.

Enzalutamide was approved by the FDA in 2012, but was not authorised in China for another seven years, partly due to a requirement for separate trials to be carried out there.

The analysis by members of the Bloomberg New Economy International Cancer Coalition found that 284,000 years of patient lives could have been saved if other countries had approved the drug alongside the FDA.

Extrapolating out from their findings, the researchers estimated that if each of the approximately seven cancer drugs approved by the FDA a year were authorised worldwide, it would reduce the number of cancer-related deaths by 10-20 percent. 

That represents roughly 1.5 million of the around 10 million people who die of cancer every year.

Advertisement
20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
previous arrow
next arrow

‘Challenging’ for doctors

“In China alone an estimated 500,000 patient life-years could be saved through harmonisation of trial requirements that have delayed patient access to treatment,” former Australian prime minister Kevin Rudd, co-chair of the Bloomberg cancer coalition, said in a statement.

Mary Gospodarowicz, also a member of the coalition, said that it was “challenging” as an oncologist in Canada when a drug was approved in the US but would take years to be able to prescribe it to her patients. 

The study assumed that the rest of the world had the infrastructure to diagnose and treat cancer as well as the US, which is not always the case, Gospodarowicz told AFP via phone from the World Cancer Congress in Geneva on Tuesday.

But it served as an example of how “removing the barriers to drug approval would be beneficial to patients around the world,” said the former president of the Union for International Cancer Control, which is holding the congress. 

The authors of the analysis called on countries to embrace Project Orbis, a US-led framework aiming to get cancer drugs trialled and approved at the same time in multiple countries.

Advertisement
20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL
previous arrow
next arrow

“The US has already made significant progress in setting up the regulatory infrastructure for cancer treatment with the Project Orbis initiative and the task ahead is to take that framework and internationalise it,” former New York mayor Michael Bloomberg said in a statement. 

Continue Reading
Advertisement
20251101_amnistia_mh_cuotas_300x250
20251101_amnistia_mh_sin_multas_300x250
20251101_amnistia_mh_sin_intereses_300x250
20250701_dengue_300x250_01
20250701_dengue_300x250_02
20250901_vacunacion_vsr-300x250
20250901_vacunacion_tetravalente-300x250
20250701_vacunacion-influenza-300x250
20250701_vacunacion_vph-300x250
20250715_donacion_sangre_central_300x250
20231124_etesal_300x250_1
20230601_agenda_primera_infancia_300X250
MARN1

International

Meta Says Russia Seeks to Ban WhatsApp for Defending Secure Communication

U.S. tech giant Meta, the parent company of WhatsApp, said that Russia is seeking to ban the messaging app because it “challenges government attempts to violate people’s right to secure communication.”

Russian authorities have encouraged citizens to switch to state-backed applications, and in August they already blocked WhatsApp’s calling feature.

On Friday, the communications regulator Roskomnadzor claimed that the platform was being used to “organize and carry out terrorist acts in the country, recruit perpetrators, and facilitate fraud and other crimes.”

“If the messaging service does not comply with Russian law, it will be completely blocked,” the regulator warned.

WhatsApp remains one of Russia’s most widely used messaging services, alongside Telegram.

Advertisement

20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL

previous arrow
next arrow

Moscow is pressuring both platforms to grant authorities access to user data upon request for investigations into fraud and activities the government labels as “terrorist.”

Human rights advocates fear the demand could be used to target critics of the Kremlin, President Vladimir Putin, or the war in Ukraine.

Continue Reading

International

Archbishop Wenski criticizes Trump’s deportation policies, calls for stronger push for reform

The Archbishop of Miami, Thomas Wenski, has called for increased pressure on the U.S. Congress to advance comprehensive immigration reform and criticized President Donald Trump’s mass deportation policies, arguing that they “do nothing to help.”

“We need to apply more pressure on Congress so lawmakers can make the necessary changes. It is also important for the Administration to listen to our voice. We do not want to be anyone’s enemy—we are Americans,” Wenski said in an interview with EFE.

The religious leader, who heads one of the dioceses with the largest Latino and Haitian populations in the United States, issued a call to defend the rights of migrants. He also emphasized that the U.S. Conference of Catholic Bishops (USCCB) has maintained a strong and public stance in favor of migrants for decades.

Continue Reading

International

Trump relaunches diplomatic push to finalize U.S.-Backed peace plan for Ukraine War

U.S. President Donald Trump announced on Tuesday that his diplomatic team will resume meetings with delegations from Russia and Ukraine in an effort to pressure both sides to accept the peace plan proposed by Washington to end the war in Ukraine.

As part of this new round of talks, U.S. Special Envoy Steve Witkoff will travel to Moscow to meet with Russian President Vladimir Putin. Meanwhile, Army Secretary Dan Driscoll will hold discussions with Ukrainian representatives to narrow differences on the remaining points of the agreement.

Trump also confirmed his intention to meet personally with Ukrainian President Volodymyr Zelensky and with Putin, though he emphasized that such meetings will only take place “when the agreement is fully finalized or in its final stage.”

The president claimed that his administration has made “tremendous progress” toward resolving the conflict and reiterated that the war “never would have started” if he had been in the White House at the onset of the crisis.

The U.S.-backed peace plan consists of 28 points and has been revised following feedback from both sides. According to Trump, only “a few points of disagreement” remain under active discussion.

Advertisement

20251101_amnistia_mh_cuotas_728x90
20251101_amnistia_mh_sin_intereres_728x90
20251101_amnistia_mh_sin_multas_728x90
20250701_dengue_728x90
20250901_vacunacion_vsr-728x90
20250901_minsal_tetra_-728x90
20250701_vacunacion-influenza-728x90
20250701_vacunacion_vph-728x90
20250715_donacion_sangre_central_728x90
20231124_etesal_728x90_1
20230601_agenda_primera_infancia_728X90
domfuturo_netview-728x90
20240604_dom_728x90
CEL

previous arrow
next arrow

One of the most controversial aspects of the proposal is the suggestion that Ukraine cede parts of the Donbas region to Russia and limit the size of its armed forces. Kyiv is working closely with Washington to soften these clauses in search of an arrangement that does not compromise its sovereignty or security.

With this diplomatic push, Trump aims to solidify his role as the main mediator in the conflict and steer the war toward a political resolution after years of devastation, humanitarian crisis, and rising global geopolitical tensions.

Continue Reading
Advertisement
20251101_amnistia_mh_cuotas_300x250
20251101_amnistia_mh_sin_multas_300x250
20251101_amnistia_mh_sin_intereses_300x250
20250701_dengue_300x250_01
20250701_dengue_300x250_02
20250901_vacunacion_vsr-300x250
20250901_vacunacion_tetravalente-300x250
20250701_vacunacion-influenza-300x250
20250701_vacunacion_vph-300x250
20250715_donacion_sangre_central_300x250
20231124_etesal_300x250_1
20230601_agenda_primera_infancia_300X250
MARN1

Trending

Central News